Clotting disorders can affect the course of a pregnancy because the body naturally increases its ability to clot during this time to prevent excessive bleeding during childbirth. In individuals with an underlying predisposition to “sticky blood,” this normal physiological shift can sometimes become exaggerated, leading to issues with the development or function of the placenta. While many women with clotting disorders have healthy, successful pregnancies, the presence of these conditions requires careful monitoring and a proactive management plan. Understanding the relationship between the circulatory system and pregnancy helps expectant parents and healthcare teams work together to support a safe environment for both the mother and the developing baby.
What We’ll Discuss in This Article
- How pregnancy naturally changes the blood-clotting system
- The impact of inherited disorders like Factor V Leiden
- Complications associated with antiphospholipid syndrome (APS)
- Potential risks to the placenta and foetal growth
- Strategies for monitoring and managing high-risk pregnancies
- Postpartum considerations for those with clotting disorders
Pregnancy and the Natural Clotting Balance
Pregnancy induces a state of “hypercoagulability,” where the levels of pro-clotting proteins in the blood increase and the levels of natural anticoagulants decrease. This is an evolutionary adaptation designed to protect against major haemorrhage at the time of delivery, but it also means that the baseline risk for a blood clot is higher for every pregnant person compared to when they are not pregnant. For someone who already has a clotting disorder, this shift can push the body’s clotting mechanism past a safe threshold. This increased activity can affect the small blood vessels in the womb and the placenta, which are essential for transporting nutrients and oxygen to the foetus.
Risks Associated with Inherited Thrombophilia
Inherited clotting disorders, such as Factor V Leiden or Protein S deficiency, primarily increase the risk of the mother developing a deep vein thrombosis or pulmonary embolism during the nine months of pregnancy and the weeks following birth. While these genetic traits are less commonly linked to direct pregnancy loss than autoimmune disorders, they can sometimes contribute to complications such as pre-eclampsia or placental abruption. The NHS provides guidance for women with a known history of blood clots or thrombophilia to ensure they receive an early referral to specialist obstetric services for a personalised care plan. In many cases, the main goal is to prevent a clot in the mother’s legs or lungs.
Antiphospholipid Syndrome and Pregnancy Loss
Antiphospholipid syndrome (APS) is one of the most significant acquired clotting disorders related to pregnancy complications. The abnormal antibodies found in APS can mistakenly attack the tissues of the developing placenta, leading to restricted blood flow and inflammation. This interference is a recognised cause of recurrent early pregnancy loss, as well as complications later in pregnancy such as restricted foetal growth or stillbirth. NICE guidelines recommend specific treatment pathways, often involving low-dose aspirin and heparin, to improve the chances of a successful pregnancy outcome for women diagnosed with APS. With appropriate treatment, most women with APS can go on to have a healthy baby.
Placental Health and Growth Issues
When a clotting disorder affects the small vessels within the placenta, it can lead to placental insufficiency, where the baby does not receive adequate support for optimal growth. This may result in a condition known as small for gestational age (SGA) or intrauterine growth restriction (IUGR). In some instances, the increased clotting activity can trigger pre-eclampsia, a condition characterised by high blood pressure and protein in the urine, which can be dangerous for both the parent and the child. Regular ultrasound scans and blood pressure monitoring are standard in the UK for managing these risks and ensuring that any signs of placental distress are identified as early as possible.
Clinical Management and Preventative Care
The management of a pregnancy complicated by a clotting disorder focuses on maintaining a healthy balance in the blood without increasing the risk of bleeding. For many women, this involves the use of daily low-dose aspirin or injections of low-molecular-weight heparin, which help to prevent microscopic clots from forming in the placenta. These medications are carefully monitored by a multidisciplinary team that usually includes a consultant obstetrician, a midwife, and a haematologist. The Royal College of Obstetricians and Gynaecologists provides detailed clinical green-top guidelines for the prevention and management of venous thromboembolism during pregnancy and the postnatal period.
Postpartum Risks and Recovery
The risk of developing a blood clot remains elevated for at least six weeks after giving birth, particularly if the delivery involved a caesarean section or if the mother experienced significant immobility. This period, known as the puerperium, is actually the time of highest risk for many women with clotting disorders. Healthcare providers often recommend continuing preventative treatment for several weeks following delivery to ensure a safe recovery. It is also important for new parents to stay hydrated and remain as mobile as possible during this time to support healthy circulation while the body’s clotting system gradually returns to its pre-pregnancy state.
Conclusion
Clotting disorders can introduce specific challenges during pregnancy, but with early diagnosis and specialist care, these risks are highly manageable. The primary focus is on protecting placental function and preventing maternal blood clots through evidence-based preventative measures. UK healthcare standards ensure that women with these conditions receive the necessary support for a healthy pregnancy and recovery. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Will I have to have a caesarean section if I have a clotting disorder?
No, having a clotting disorder does not automatically mean you need a caesarean section; many women are able to have a standard vaginal birth with a managed plan.
Is heparin safe for the baby during pregnancy?
Yes, low-molecular-weight heparin does not cross the placenta and is considered safe for the developing baby when used under medical supervision.
Does Factor V Leiden cause morning sickness?
There is no clinical evidence to suggest that Factor V Leiden or other clotting disorders have any effect on the severity of morning sickness.
When should I start taking aspirin if I have APS?
If you have a diagnosis of APS, your consultant will usually recommend starting low-dose aspirin either when you begin trying to conceive or as soon as you have a positive pregnancy test.
Can I still breastfeed if I am taking blood thinners?
Most standard anticoagulants used after pregnancy, such as heparin and warfarin, are compatible with breastfeeding; your doctor will confirm the best option for you.
Do I need extra scans during my pregnancy?
Yes, it is common to have additional growth scans to monitor the baby’s development and the blood flow through the umbilical cord if you have a clotting disorder.
Will my baby be born with the same clotting disorder?
If the disorder is inherited, there is a chance the baby could inherit the gene, but they will not necessarily experience any health issues during childhood.
Authority Snapshot (E-E-A-T)
This article provides information regarding the impact of clotting disorders on pregnancy in alignment with UK obstetric and haematological standards. The content is reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and acute care settings where the complications of “sticky blood” are managed. All information is strictly grounded in the clinical guidelines and safety protocols provided by the NHS and NICE.
